APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemical API CDMO

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chemical API CDMO Market Outlook and Growth Opportunities 2026

4 January 2026204 pages

Choose your research edition.

Industry ResearchChemical API CDMO Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemical API CDMO Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Chemical API CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemical API CDMO Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemical API CDMO Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Chemical API CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chemical API CDMO market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chemical API CDMO market include Flamma Group, HAS Healthcare, Asymchem, Recipharm, Pierre Fabre, Pfizer CentreOne, Axplora, Lonza and MAI CDMO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chemical API CDMO market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chemical API CDMO and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chemical API CDMO revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chemical API CDMO market.

Chemical API CDMO Segment by Company

Flamma Group

HAS Healthcare

Asymchem

Recipharm

Pierre Fabre

Pfizer CentreOne

Axplora

Lonza

MAI CDMO

BioVectra

Curia

AGC Pharma Chemicals

Asymchem

Olon Group

Evonik Health Care

Teva Active Pharmaceutical Ingredients

Chemical API CDMO Segment by Type

Small Molecule CDMO

Macromolecule CDMO

Cell Gene Therapy (CGT) CDMO

Chemical API CDMO Segment by Application

Pharmaceutical and Biotechnology Companies

Research and Academic Institutions

Hospital

Others

Chemical API CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chemical API CDMO status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chemical API CDMO key companies, revenue, market share, and recent developments.

3. To split the Chemical API CDMO breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chemical API CDMO market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chemical API CDMO significant trends, drivers, influence factors in global and regions.

6. To analyze Chemical API CDMO competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical API CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemical API CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical API CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chemical API CDMO industry.

Chapter 3: Detailed analysis of Chemical API CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chemical API CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chemical API CDMO in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chemical API CDMO Industry Trends Table 2. Chemical API CDMO Industry Drivers Table 3. Chemical API CDMO Industry Opportunities and Challenges Table 4. Chemical API CDMO Industry Restraints Table 5. Global Chemical API CDMO Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chemical API CDMO Revenue Share by Company (2021-2026) Table 7. Global Chemical API CDMO Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chemical API CDMO Key Company Manufacturing Base & Headquarters Table 9. Global Chemical API CDMO Company, Product Type & Application Table 10. Global Chemical API CDMO Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chemical API CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Small Molecule CDMO Table 15. Significant Companies of Macromolecule CDMO Table 16. Significant Companies of Cell Gene Therapy (CGT) CDMO Table 17. Global Chemical API CDMO Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Chemical API CDMO Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Chemical API CDMO Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Chemical API CDMO Sales Value Share by Type (2021-2026) Table 21. Global Chemical API CDMO Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical and Biotechnology Companies Table 23. Significant Companies of Research and Academic Institutions Table 24. Significant Companies of Hospital Table 25. Significant Companies of Others Table 26. Global Chemical API CDMO Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Chemical API CDMO Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Chemical API CDMO Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Chemical API CDMO Sales Value Share by Application (2021-2026) Table 30. Global Chemical API CDMO Sales Value Share by Application (2027-2032) Table 31. Global Chemical API CDMO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Chemical API CDMO Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Chemical API CDMO Sales Value Share by Region (2021-2026) Table 34. Global Chemical API CDMO Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Chemical API CDMO Sales Value Share by Region (2027-2032) Table 36. Global Chemical API CDMO Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Chemical API CDMO Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Chemical API CDMO Sales Value Market Share by Country (2021-2026) Table 39. Global Chemical API CDMO Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Chemical API CDMO Sales Value Market Share by Country (2027-2032) Table 41. Flamma Group Company Information Table 42. Flamma Group Business Overview Table 43. Flamma Group Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Flamma Group Chemical API CDMO Product Portfolio Table 45. Flamma Group Recent Development Table 46. HAS Healthcare Company Information Table 47. HAS Healthcare Business Overview Table 48. HAS Healthcare Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. HAS Healthcare Chemical API CDMO Product Portfolio Table 50. HAS Healthcare Recent Development Table 51. Asymchem Company Information Table 52. Asymchem Business Overview Table 53. Asymchem Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Asymchem Chemical API CDMO Product Portfolio Table 55. Asymchem Recent Development Table 56. Recipharm Company Information Table 57. Recipharm Business Overview Table 58. Recipharm Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Recipharm Chemical API CDMO Product Portfolio Table 60. Recipharm Recent Development Table 61. Pierre Fabre Company Information Table 62. Pierre Fabre Business Overview Table 63. Pierre Fabre Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Pierre Fabre Chemical API CDMO Product Portfolio Table 65. Pierre Fabre Recent Development Table 66. Pfizer CentreOne Company Information Table 67. Pfizer CentreOne Business Overview Table 68. Pfizer CentreOne Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Pfizer CentreOne Chemical API CDMO Product Portfolio Table 70. Pfizer CentreOne Recent Development Table 71. Axplora Company Information Table 72. Axplora Business Overview Table 73. Axplora Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Axplora Chemical API CDMO Product Portfolio Table 75. Axplora Recent Development Table 76. Lonza Company Information Table 77. Lonza Business Overview Table 78. Lonza Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Lonza Chemical API CDMO Product Portfolio Table 80. Lonza Recent Development Table 81. MAI CDMO Company Information Table 82. MAI CDMO Business Overview Table 83. MAI CDMO Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. MAI CDMO Chemical API CDMO Product Portfolio Table 85. MAI CDMO Recent Development Table 86. BioVectra Company Information Table 87. BioVectra Business Overview Table 88. BioVectra Chemical API CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. BioVectra Chemical API CDMO Product Portfolio Table 90. BioVectra Recent Development Table 91. Curia Company Information Table 92. Curia Business Overview Table 93. Curia Chemical API CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Curia Chemical API CDMO Product Portfolio Table 95. Curia Recent Development Table 96. AGC Pharma Chemicals Company Information Table 97. AGC Pharma Chemicals Business Overview Table 98. AGC Pharma Chemicals Chemical API CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. AGC Pharma Chemicals Chemical API CDMO Product Portfolio Table 100. AGC Pharma Chemicals Recent Development Table 101. Asymchem Company Information Table 102. Asymchem Business Overview Table 103. Asymchem Chemical API CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Asymchem Chemical API CDMO Product Portfolio Table 105. Asymchem Recent Development Table 106. Olon Group Company Information Table 107. Olon Group Business Overview Table 108. Olon Group Chemical API CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Olon Group Chemical API CDMO Product Portfolio Table 110. Olon Group Recent Development Table 111. Evonik Health Care Company Information Table 112. Evonik Health Care Business Overview Table 113. Evonik Health Care Chemical API CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Evonik Health Care Chemical API CDMO Product Portfolio Table 115. Evonik Health Care Recent Development Table 116. Teva Active Pharmaceutical Ingredients Company Information Table 117. Teva Active Pharmaceutical Ingredients Business Overview Table 118. Teva Active Pharmaceutical Ingredients Chemical API CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Teva Active Pharmaceutical Ingredients Chemical API CDMO Product Portfolio Table 120. Teva Active Pharmaceutical Ingredients Recent Development Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Chemical API CDMO Product Image Figure 2. Global Chemical API CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemical API CDMO Market Size (2021-2032) & (US$ Million) Figure 4. Global Chemical API CDMO Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Small Molecule CDMO Image Figure 8. Macromolecule CDMO Image Figure 9. Cell Gene Therapy (CGT) CDMO Image Figure 10. Global Chemical API CDMO Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Chemical API CDMO Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Chemical API CDMO Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical and Biotechnology Companies Image Figure 14. Research and Academic Institutions Image Figure 15. Hospital Image Figure 16. Others Image Figure 17. Global Chemical API CDMO Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Chemical API CDMO Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Chemical API CDMO Sales Value Share by Application (2021-2032) Figure 20. Global Chemical API CDMO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Chemical API CDMO Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Chemical API CDMO Sales Value (2021-2032) & (US$ Million) Figure 23. North America Chemical API CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Chemical API CDMO Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Chemical API CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Chemical API CDMO Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Chemical API CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Chemical API CDMO Sales Value (2021-2032) & (US$ Million) Figure 29. South America Chemical API CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Chemical API CDMO Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Chemical API CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Chemical API CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Chemical API CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Chemical API CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule CDMO
  • Macromolecule CDMO
  • Cell Gene Therapy (CGT) CDMO
Applications
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutions
  • Hospital
  • Others
Companies covered
  • Flamma Group
  • HAS Healthcare
  • Asymchem
  • Recipharm
  • Pierre Fabre
  • Pfizer CentreOne
  • Axplora
  • Lonza
  • MAI CDMO
  • BioVectra
  • Curia
  • AGC Pharma Chemicals
  • Asymchem
  • Olon Group
  • Evonik Health Care
  • Teva Active Pharmaceutical Ingredients

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chemical API CDMO Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chemical API CDMO Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chemical API CDMO Market Dynamics
  1. 2.1 Chemical API CDMO Industry Trends
  2. 2.2 Chemical API CDMO Industry Drivers
  3. 2.3 Chemical API CDMO Industry Opportunities and Challenges
  4. 2.4 Chemical API CDMO Industry Restraints
3 Chemical API CDMO Market by Company
  1. 3.1 Global Chemical API CDMO Company Revenue Ranking in 2025
  2. 3.2 Global Chemical API CDMO Revenue by Company (2021-2026)
  3. 3.3 Global Chemical API CDMO Company Ranking (2024-2026)
  4. 3.4 Global Chemical API CDMO Company Manufacturing Base and Headquarters
  5. 3.5 Global Chemical API CDMO Company Product Type and Application
  6. 3.6 Global Chemical API CDMO Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chemical API CDMO Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chemical API CDMO Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chemical API CDMO Market by Type
  1. 4.1 Chemical API CDMO Type Introduction
  2. 4.1.1 Small Molecule CDMO
  3. 4.1.2 Macromolecule CDMO
  4. 4.1.3 Cell Gene Therapy (CGT) CDMO
  5. 4.2 Global Chemical API CDMO Sales Value by Type
  6. 4.2.1 Global Chemical API CDMO Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Chemical API CDMO Sales Value by Type (2021-2032)
  8. 4.2.3 Global Chemical API CDMO Sales Value Share by Type (2021-2032)
5 Chemical API CDMO Market by Application
  1. 5.1 Chemical API CDMO Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 Research and Academic Institutions
  4. 5.1.3 Hospital
  5. 5.1.4 Others
  6. 5.2 Global Chemical API CDMO Sales Value by Application
  7. 5.2.1 Global Chemical API CDMO Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Chemical API CDMO Sales Value by Application (2021-2032)
  9. 5.2.3 Global Chemical API CDMO Sales Value Share by Application (2021-2032)
6 Chemical API CDMO Regional Value Analysis
  1. 6.1 Global Chemical API CDMO Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chemical API CDMO Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chemical API CDMO Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chemical API CDMO Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chemical API CDMO Sales Value (2021-2032)
  7. 6.3.2 North America Chemical API CDMO Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chemical API CDMO Sales Value (2021-2032)
  10. 6.4.2 Europe Chemical API CDMO Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chemical API CDMO Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chemical API CDMO Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chemical API CDMO Sales Value (2021-2032)
  16. 6.6.2 South America Chemical API CDMO Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chemical API CDMO Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chemical API CDMO Sales Value Share by Country, 2025 VS 2032
7 Chemical API CDMO Country-level Value Analysis
  1. 7.1 Global Chemical API CDMO Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chemical API CDMO Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chemical API CDMO Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chemical API CDMO Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chemical API CDMO Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chemical API CDMO Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chemical API CDMO Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chemical API CDMO Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chemical API CDMO Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chemical API CDMO Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chemical API CDMO Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chemical API CDMO Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chemical API CDMO Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chemical API CDMO Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chemical API CDMO Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chemical API CDMO Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chemical API CDMO Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chemical API CDMO Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chemical API CDMO Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chemical API CDMO Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chemical API CDMO Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chemical API CDMO Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chemical API CDMO Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chemical API CDMO Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chemical API CDMO Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chemical API CDMO Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chemical API CDMO Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chemical API CDMO Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chemical API CDMO Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chemical API CDMO Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chemical API CDMO Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chemical API CDMO Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chemical API CDMO Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chemical API CDMO Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Flamma Group
  2. 8.1.1 Flamma Group Company Information
  3. 8.1.2 Flamma Group Business Overview
  4. 8.1.3 Flamma Group Chemical API CDMO Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Flamma Group Chemical API CDMO Product Portfolio
  6. 8.1.5 Flamma Group Recent Developments
  7. 8.2 HAS Healthcare
  8. 8.2.1 HAS Healthcare Company Information
  9. 8.2.2 HAS Healthcare Business Overview
  10. 8.2.3 HAS Healthcare Chemical API CDMO Revenue and Gross Margin (2021-2026)
  11. 8.2.4 HAS Healthcare Chemical API CDMO Product Portfolio
  12. 8.2.5 HAS Healthcare Recent Developments
  13. 8.3 Asymchem
  14. 8.3.1 Asymchem Company Information
  15. 8.3.2 Asymchem Business Overview
  16. 8.3.3 Asymchem Chemical API CDMO Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Asymchem Chemical API CDMO Product Portfolio
  18. 8.3.5 Asymchem Recent Developments
  19. 8.4 Recipharm
  20. 8.4.1 Recipharm Company Information
  21. 8.4.2 Recipharm Business Overview
  22. 8.4.3 Recipharm Chemical API CDMO Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Recipharm Chemical API CDMO Product Portfolio
  24. 8.4.5 Recipharm Recent Developments
  25. 8.5 Pierre Fabre
  26. 8.5.1 Pierre Fabre Company Information
  27. 8.5.2 Pierre Fabre Business Overview
  28. 8.5.3 Pierre Fabre Chemical API CDMO Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pierre Fabre Chemical API CDMO Product Portfolio
  30. 8.5.5 Pierre Fabre Recent Developments
  31. 8.6 Pfizer CentreOne
  32. 8.6.1 Pfizer CentreOne Company Information
  33. 8.6.2 Pfizer CentreOne Business Overview
  34. 8.6.3 Pfizer CentreOne Chemical API CDMO Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer CentreOne Chemical API CDMO Product Portfolio
  36. 8.6.5 Pfizer CentreOne Recent Developments
  37. 8.7 Axplora
  38. 8.7.1 Axplora Company Information
  39. 8.7.2 Axplora Business Overview
  40. 8.7.3 Axplora Chemical API CDMO Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Axplora Chemical API CDMO Product Portfolio
  42. 8.7.5 Axplora Recent Developments
  43. 8.8 Lonza
  44. 8.8.1 Lonza Company Information
  45. 8.8.2 Lonza Business Overview
  46. 8.8.3 Lonza Chemical API CDMO Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lonza Chemical API CDMO Product Portfolio
  48. 8.8.5 Lonza Recent Developments
  49. 8.9 MAI CDMO
  50. 8.9.1 MAI CDMO Company Information
  51. 8.9.2 MAI CDMO Business Overview
  52. 8.9.3 MAI CDMO Chemical API CDMO Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MAI CDMO Chemical API CDMO Product Portfolio
  54. 8.9.5 MAI CDMO Recent Developments
  55. 8.10 BioVectra
  56. 8.10.1 BioVectra Company Information
  57. 8.10.2 BioVectra Business Overview
  58. 8.10.3 BioVectra Chemical API CDMO Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BioVectra Chemical API CDMO Product Portfolio
  60. 8.10.5 BioVectra Recent Developments
  61. 8.11 Curia
  62. 8.11.1 Curia Company Information
  63. 8.11.2 Curia Business Overview
  64. 8.11.3 Curia Chemical API CDMO Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Curia Chemical API CDMO Product Portfolio
  66. 8.11.5 Curia Recent Developments
  67. 8.12 AGC Pharma Chemicals
  68. 8.12.1 AGC Pharma Chemicals Company Information
  69. 8.12.2 AGC Pharma Chemicals Business Overview
  70. 8.12.3 AGC Pharma Chemicals Chemical API CDMO Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AGC Pharma Chemicals Chemical API CDMO Product Portfolio
  72. 8.12.5 AGC Pharma Chemicals Recent Developments
  73. 8.13 Asymchem
  74. 8.13.1 Asymchem Company Information
  75. 8.13.2 Asymchem Business Overview
  76. 8.13.3 Asymchem Chemical API CDMO Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Asymchem Chemical API CDMO Product Portfolio
  78. 8.13.5 Asymchem Recent Developments
  79. 8.14 Olon Group
  80. 8.14.1 Olon Group Company Information
  81. 8.14.2 Olon Group Business Overview
  82. 8.14.3 Olon Group Chemical API CDMO Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Olon Group Chemical API CDMO Product Portfolio
  84. 8.14.5 Olon Group Recent Developments
  85. 8.15 Evonik Health Care
  86. 8.15.1 Evonik Health Care Company Information
  87. 8.15.2 Evonik Health Care Business Overview
  88. 8.15.3 Evonik Health Care Chemical API CDMO Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Evonik Health Care Chemical API CDMO Product Portfolio
  90. 8.15.5 Evonik Health Care Recent Developments
  91. 8.16 Teva Active Pharmaceutical Ingredients
  92. 8.16.1 Teva Active Pharmaceutical Ingredients Company Information
  93. 8.16.2 Teva Active Pharmaceutical Ingredients Business Overview
  94. 8.16.3 Teva Active Pharmaceutical Ingredients Chemical API CDMO Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Teva Active Pharmaceutical Ingredients Chemical API CDMO Product Portfolio
  96. 8.16.5 Teva Active Pharmaceutical Ingredients Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst